abnormal motor capabilities/coordination/movement_Brca2<tm1Mbn>/Brca2<+>

http://metadb.riken.jp/0002066I129P2OlaHsd129SSvEvBrca2tm1MbnBrca2Brca2tm1MbnBrca2

abnormal motor capabilities/coordination/movement_Brca2<tm1Mbn>/Brca2<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• breast cancer 2, early onset
  http://metadb.riken.jp/db/mgi_rdf/MGI:109337

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Brca2<tm1Mbn>/Brca2<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Brca2<tm1Mbn>|Brca2<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * 129S/SvEv

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal motor capabilities/coordination/movement
  http://purl.obolibrary.org/obo/MP_0002066

文献

http://purl.org/net/cito/citesAsAuthority

• L M. Bennett, et.al., BRCA2-null embryonic survival is prolonged on the BALB/c genetic background., Molecular carcinogenesis, 2000, 28
  http://rdf.ncbi.nlm.nih.gov/pubmed/10942534